Erschienen in:
30.09.2019 | Pituitary Adenoma
A tale of pituitary adenomas: to NET or not to NET
Pituitary Society position statement
verfasst von:
Ken K. Y. Ho, Maria Fleseriu, John Wass, Aart van der Lely, Ariel Barkan, Andrea Giustina, Felipe F. Casanueva, Anthony P. Heaney, Nienke Biermasz, Christian Strasburger, Shlomo Melmed
Erschienen in:
Pituitary
|
Ausgabe 6/2019
Einloggen, um Zugang zu erhalten
Excerpt
Anterior pituitary tumors arising from oral ectoderm-derived differentiated hormone-expressing lineages are classified according to cell type, size, location, secretory function and neoplastic behavior. The pathological classification of pituitary tumors has been driven by advances in physiology, cell biology and genetics. Almost all pituitary adenomas are benign neoplasms; extremely rarely, some may undergo malignant transformation, metastasizing to extracranial sites. An intermediate group of higher risk locally invasive adenomas are described as ‘atypical’ or ‘aggressive’ based on clinical features. …